|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| A61P 35/00 |
| (11) | Patento numeris | 2205257 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08836333.8 |
| Europos patento paraiškos padavimo data | 2008-10-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-07-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-09-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2008/002653 |
| Data | 2008-10-03 |
| (87) | Numeris | WO 2009/044273 |
| Data | 2009-04-09 |
| (30) | Numeris | Data | Šalis |
| 07291214 | 2007-10-05 | EP |
| (72) |
TRIEBEL, Frédéric, FR
|
| (73) |
Immutep,
Parc Club Orsay 2, Rue Jean Rostand, 91400 Orsay,
FR
|
| (54) | LAG-3Ig (IMP321) dosage regimes for use in the treatment of cancer |
| LAG-3Ig (IMP321) dosage regimes for use in the treatment of cancer |